🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#28 No sun. No soil. Still: over a ton of veggies in #Antarctica. #DLR & #AWI show how food production could work in extreme environments. 🔗 Find out how: t1p.de/kfofu #EDENISS

Save the Date – #EnergySymposium 2025 June 24–27 | Karlsruhe (KIT) Four days of inspiration: keynotes, science slam, workshops & presentations by excellent speakers. Connect with leading minds in #energyresearch! More info: energy.helmholtz.de/energy-symposi…

#29 A broken bone, one surgery, full healing. @[email protected] is helping develop implants that disappear when no longer needed. 🔗 Discover the science: t1p.de/ngktq

#30 #Robots on ice or in space: The #ROBEX alliance by #AWI, #GEOMAR & #DLR pushes science to the edge— with autonomous systems for the extremes. 🔗 Explore the story: t1p.de/9bdb7

Zeynep Akata Receives 2025 ZukunftsWissen Award 👏 Congratulations to Prof. Zeynep Akata on receiving the 2025 ZukunftsWissen Award from the German National Academy of Sciences Leopoldina and the Commerzbank Foundation. 👉 t1p.de/kdajf 💡 Her research focuses on

🚀 Job Alert Friday! 🚀 💼 Role: PhD Student in Advanced Methods for Sustainability Assessment of PV Systems Helmholtz-Zentrum Berlin 👉 Apply now: recruitingapp-5181.de.umantis.com/Vacancies/2591… Explore more opportunities in Data Science, Machine Learning and AI within HelmholtzAssociation: helmholtz-hida.de/en/jobs/job-of…

A recent study maps where language models already help in clinical practice and where they fall short. We spoke with lead researcher Altuna Akalin about the opportunities and limits of human-like AI in everyday medicine. Read more ⤵️ helmholtz.de/en/newsroom/ar…

Helmholtz Munich Wins M4 Award 2025 for RNA Therapy Spin-off Project 🏆 👉t1p.de/6fyup Researchers at #HelmholtzMunich have received the m4 Award 2025, a pre-seed competition that supports promising biomedical spin-offs in Bavaria. The award was presented during the

🚀 Job Alert Friday! 🚀 Exciting Opportunity DKFZ 💼 Role: Postdoctoral Researcher – Longitudinal Proteomic Analysis 👉 Apply now: jobs.dkfz.de/en/jobs/167852… Explore more opportunities in Data Science, Machine Learning and AI within HelmholtzAssociation: helmholtz-hida.de/en/jobs/job-of…

„We remain deeply distressed by the ongoing war in #Gaza, the hostage crisis and the #Palestinian humanitarian crisis….We at Weizmann are facing challenges head-on and continuing in our mission as we always have: by advancing #science that protects and sustains life, and doing

Here comes part 6 of our series on quantum mechanics: Tap-proof quantum communication. Read more ⤵️ helmholtz.de/en/newsroom/ar…

Pauline Holfelder receives the MTZ-Helmholtz Health Award 2025. 🎉 She was honored for her groundbreaking research on the molecular mechanisms of glioblastoma. Read more here ⤵️ helmholtz.de/en/newsroom/ar… DKFZ 📸 Oliver Walterscheid

🚀 Job Alert Friday! 🚀 💼 Role: Postdoctoral Researcher – Fine-tuning LLMs and Agentic Systems for Physics and Materials Science Forschungszentrum Jülich | @[email protected] 👉 Apply now: fz-juelich.de/en/careers/job… Explore more job opportunities within HelmholtzAssociation: helmholtz-hida.de/en/jobs/job-of…

Researchers from the DKFZ and Universitätsklinikum Heidelberg are presenting an innovative approach that uses artificial intelligence and hyperspectral #imaging to enable faster #sepsis diagnosis directly at the bedside. Lena Maier-Hein New: @lena-maier-hein.bsky.social IMSY Lab (DKFZ) t1p.de/b7vmz

Helmholtz researchers are developing a precise, adaptive digital model of the cell. This model is fed millions of pieces of biological data and is ready for virtual experiments. Learn more about the #VirtualCell Project here ⤵️ helmholtz.de/en/newsroom/ar… Fabian Theis

Therapeutic Vaccine for Chronic Hepatitis B Enters Patient Trial 🧪 👉 t1p.de/qcncm 💡 #TherVacB aims to activate the natural immune response in a way that could finally enable the body to eliminate the virus. Following a successful phase 1a trial in healthy